Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis

被引:30
作者
Barber, SA
Uhrlaub, JL
DeWitt, JB
Tarwater, PM
Zink, MC
机构
[1] Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21287 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Biometry, El Paso, TX 79968 USA
关键词
D O I
10.1016/S0002-9440(10)63125-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Central nervous system (CNS) disease is a frequent complication of human immunodeficiency virus (HIV)-1 infection. identification of cellular mechanisms that control virus replication and that mediate development of HIV-associated neuropathology will provide novel strategies for therapeutic intervention. The milieu of the CNS during HINT infection is extraordinarily complex because of infiltration of inflammatory cells and production of chemokines, cytokines, and neurotoxic molecules. Cells in the CNS must integrate signaling pathways activated simultaneously by products of virus replication and infiltrating immune cells. in this study, we examined activation of mitogen-activated protein kinases (MAPKs) in the CNS of simian immunodeficiency virus-infected macaques during acute, asymptomatic, and terminal infection. We demonstrate that significantly increased (P < 0.02) activation of ERK MAPK, typically associated with anti-apoptotic and neuroprotective pathways, occurs predominantly in astrocytes and immediately precedes suppression of virus replication and macrophage activation that occur after acute infection. In contrast, significantly increased activation of proapoptotic, neurodegenerative MAPKs JNK (P = 0.03; predominantly in macrophages/microglia), and p38 (P = 0.03; predominantly in neurons and astrocytes) after acute infection correlates with subsequent resurgent virus replication and development of neurological lesions. This shift from classically neuroprotective to neurodegenerative MAPK pathways suggests that agents that inhibit activation of JNK/p38 may be protective against HINT-associated CNS disease.
引用
收藏
页码:355 / 362
页数:8
相关论文
共 67 条
[1]   Clinical pharmacokinetics of zidovudine - An update [J].
Acosta, EP ;
Page, LM ;
Fletcher, CV .
CLINICAL PHARMACOKINETICS, 1996, 30 (04) :251-262
[2]   Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis [J].
Atzori, C ;
Ghetti, B ;
Piva, R ;
Srinivasan, AN ;
Zolo, P ;
Delisle, MB ;
Mirra, SS ;
Migheli, A .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (12) :1190-1197
[3]   Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex [J].
Aweeka, F ;
Jayewardene, A ;
Staprans, S ;
Bellibas, SE ;
Kearney, B ;
Lizak, P ;
Novakovic-Agopian, T ;
Price, RW .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (01) :39-43
[4]  
BARBER SA, 1995, J IMMUNOL, V155, P1404
[5]   Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia [J].
Bjugstad, KB ;
Flitter, WD ;
Garland, WA ;
Su, GC ;
Arendash, GW .
BRAIN RESEARCH, 1998, 795 (1-2) :349-357
[6]   CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-α infusion model for AIDS dementia complex [J].
Bjugstad, KB ;
Flitter, WD ;
Garland, WA ;
Philpot, RM ;
Kirstein, CL ;
Arendash, GW .
JOURNAL OF NEUROVIROLOGY, 2000, 6 (06) :478-491
[7]   Viral load and neuropathology in the SIV model [J].
Boche, D ;
Khatissian, E ;
Gray, F ;
Falanga, P ;
Montagnier, L ;
Hurtrel, B .
JOURNAL OF NEUROVIROLOGY, 1999, 5 (03) :232-240
[8]   Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms [J].
Bonni, A ;
Brunet, A ;
West, AE ;
Datta, SR ;
Takasu, MA ;
Greenberg, ME .
SCIENCE, 1999, 286 (5443) :1358-1362
[9]   Identification of protein kinases dysregulated in CD4+ T cells in pathogenic versus apathogenic simian immunodeficiency virus infection [J].
Bostik, P ;
Wu, P ;
Dodd, GL ;
Villinger, F ;
Mayne, AE ;
Bostik, V ;
Grimm, BD ;
Robinson, D ;
Kung, HJ ;
Ansari, AA .
JOURNAL OF VIROLOGY, 2001, 75 (23) :11298-11306
[10]   Targeting the JNK Pathway for Therapeutic Benefit in CNS Disease [J].
Bozyczko-Coyne, Donna ;
Saporito, Michael S. ;
Hudkins, Robert L. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (01) :31-49